gene

AMYLOID

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6575Connections
30Hypotheses
0Analyses
50Outgoing
50Incoming
2Experiments
0Debates

Summary

AMYLOID is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 2116 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of AMYLOID

AI-generated illustration

Regenerate portrait ↻
🧬 Gene Info
Gene SymbolAMYLOID
Associated DiseasesAging, Als, Alzheimer, Alzheimer Disease, ALZHEIMER'S DISEASE
Known Drugs/CompoundsDONANEMAB, LECANEMAB, MELATONIN, NICOTINAMIDE, RAPAMYCIN, SEMAGLUTIDE
InteractionsA2M, ABCA1, ABCA7, ABI3, ACE, ACETYLCHOLINE
KG Connections4782 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

amyloid-beta-metalloproteinases

mechanism · 4656 words

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        AMYLOID["AMYLOID"] -->|"associated with"| MICROGLIA["MICROGLIA"]
        AMYLOID["AMYLOID"] -->|"associated with"| TAU["TAU"]
        AMYLOID["AMYLOID"] -->|"associated with"| BACE1["BACE1"]
        AMYLOID["AMYLOID"] -->|"associated with"| AUTOPHAGY["AUTOPHAGY"]
        AMYLOID["AMYLOID"] -->|"associated with"| APOPTOSIS["APOPTOSIS"]
        AMYLOID["AMYLOID"] -->|"associated with"| GFAP["GFAP"]
        AMYLOID["AMYLOID"] -->|"associated with"| NEURON["NEURON"]
        AMYLOID["AMYLOID"] -->|"associated with"| SOD1["SOD1"]
        AMYLOID["AMYLOID"] -->|"associated with"| NLRP3["NLRP3"]
        AKT["AKT"] -->|"associated with"| AMYLOID["AMYLOID"]
    end
    subgraph Signaling["Signaling"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER["ALZHEIMER"] -->|"activates"| AMYLOID["AMYLOID"]
        ALZHEIMER_S_DISEASE_1["ALZHEIMER'S DISEASE"] -.->|"inhibits"| AMYLOID["AMYLOID"]
        ALZHEIMER_2["ALZHEIMER"] -.->|"inhibits"| AMYLOID["AMYLOID"]
    end
    style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style BACE1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GFAP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style SOD1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NLRP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2893)

TargetRelationTypeStr
PSEN2associated_withgene1.00
Alzheimertherapeutic_targetdisease1.00
AGINGactivatesgene1.00
ALZHEIMER'S DISEASEexpressed_ingene1.00
Agingtherapeutic_targetdisease1.00

Incoming (3682)

SourceRelationTypeStr
ALZHEIMERinhibitsgene1.00
ALZHEIMERactivatesgene1.00
ALZHEIMERbiomarker_forgene1.00
APP/PS1activatesgene1.00
TAUinteracts_withgene1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop optogenetic targeting PV interneurons to restore 0.944 Alzheimer's disease Circuit-level neural dynamics in neurode
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.904 neurodegeneration TREM2 in Alzheimer's Disease: Mechanisms
Closed-loop transcranial focused ultrasound to restore hippo 0.827 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxic 0.817 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S 0.811 neurodegeneration What are the cell-type-specific transcri
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate 0.785 - Do β-amyloid plaques and neurofibrillary
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli 0.769 - Do β-amyloid plaques and neurofibrillary
Test: TREM2 enhances amyloid clearance 0.755 - Test Hypothesis Fixtures
Exposed amyloidogenic segments (β-sheet propensity residues) 0.740 protein biochemistry Do chaperones selectively recognize path
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi 0.720 neurodegeneration What are the mechanisms by which gut mic
Test: TREM2 enhances amyloid clearance 0.712 - Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance 0.705 - Test Hypothesis Fixtures
Excess orexin-A worsens AD cognition through wake-driven amy 0.686 neurodegeneration Orexin-A manipulation in AD cognition an
TREM2 Microglial Activation Rescues Amyloid Clearance in AD 0.680 neurodegeneration Test Hypothesis Fixtures
Test: TREM2 enhances amyloid clearance 0.655 - Test Hypothesis Fixtures
Amyloid-beta induces secondary pericyte senescence after con 0.640 neurodegeneration Does pericyte senescence drive BBB break
Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in 0.637 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
Test: TREM2 enhances amyloid clearance 0.637 - Test Hypothesis Fixtures
Pericyte senescence is sufficient to weaken the BBB even wit 0.630 neurodegeneration Does pericyte senescence drive BBB break
APOE4-microglial complement signaling causes cholinergic-enr 0.630 neurodegeneration What determines the temporal sequence of
Microglial ACE Enhancement for Amyloid Clearance 0.622 neurodegeneration Gene expression changes in aging mouse b
Locus coeruleus degeneration gates whether cholinergic dysfu 0.620 neurodegeneration What determines the temporal sequence of
Test: TREM2 enhances amyloid clearance 0.612 - Test Hypothesis Fixtures
Basal forebrain NGF/TrkA trophic failure is an upstream trig 0.610 neurodegeneration What determines the temporal sequence of
Temporal Decoupling of CSF p-tau217 Normalization from Amylo 0.595 neurodegeneration -
CSF p-tau217 Normalization Reflects Amyloid-Driven Tau Patho 0.586 neurodegeneration -
Myelin Breakdown-Amyloid Interaction Amplifies Cortical Agin 0.584 Alzheimer disease Allen Mouse Brain Aging Atlas: cross-age
Closed-loop transcranial focused ultrasound to restore hippo 0.564 Alzheimer's disease Circuit-level neural dynamics in neurode
Gut-derived butyrate reprograms microglia for amyloid cleara 0.000 Alzheimer's disease Gut-Brain Axis Therapeutics for AD

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
TREM2 KO amyloid pathology study validation Alzheimers Disease 0.800 0.00 Mouse (5xFAD/TREM2-/-) completed N/A
Closed-loop tFUS Enhances Glymphatic Clearance and Restores CA1 PV Int in_vivo Alzheimer's disease 0.765 0.55 APP/PS1 mice 8-11 months (n=10 proposed $125,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555] Mishra AK, Jain S ACS Chem Neurosci 2026 0
The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232] Xie Z, Tu W, Ye XF, Hua L, Zhang X et al Sci Rep 2026 0
Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] Akkaoui J, Devadoss D, Rodriguez MD, Ari Neural Regen Res 2026 0
Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359] Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki Journal of personalized medici 2026 0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] Burdman Gabriel; Akkaoui Juliet; Colon N Neurology international 2026 0
Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318] Seijo MA, Yohannes PA, Rogers AL, Gonzal Res Sq 2026 0
Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] Akkaoui J, Devadoss D, Rodriguez MD, Ari Neural regeneration research 2026 0
Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] ["Burdman G", "Akkaoui J", "Colon N", "P Neurology international 2026 0
Retinal Müller glia alterations and their impact on ocular glymphatic clearance [PMID:41603340] Das G, Raghunathan R, Wang L J Alzheimers Dis 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
The Glymphatic-Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, [PMID:41226584] ["Costea D", "Dobrin N", "Tataru C", "To International journal of molec 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Longitudinal changes of blood-brain barrier and transcytolemmal water exchange p [PMID:40089221] Xiong C, Yu Z, Yin Y Neuroimage 2025 0
The future of biomarkers for vascular contributions to cognitive impairment and [PMID:40542975] Lennon MJ, Karvelas N, Ganesh A Geroscience 2025 0
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting [PMID:38513667] Zhang D, Zhang W, Ming C, Gao X, Yuan H, Neuron 2024 0
The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disea [PMID:38852117] Balusu S, De Strooper B Acta neuropathologica 2024 0
α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B sig [PMID:37410546] Unknown JCI Insight 2023 0
Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] Dong Y, D'Mello C, Pinsky W, Lozinski BM Nature neuroscience 2021 0
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. [PMID:34069890] Burillo J, Marqués P, Jiménez B, Gonzále Cells 2021 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning AMYLOID in their description or question text

Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology

Score: 0.785 · unknown disease · 2026-04-12

## Mechanistic Overview Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbates Amyloid Pathology starts from the

Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling

Score: 0.769 · unknown disease · 2026-04-12

## Mechanistic Overview Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling starts from the cla

Test: TREM2 enhances amyloid clearance

Score: 0.755 · unknown disease · 2026-04-17

## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w

Exposed amyloidogenic segments (β-sheet propensity residues) serve as HSP70 reco

Score: 0.740 · protein biochemistry · 2026-04-21

## **Molecular Mechanism and Rationale** The recognition of amyloidogenic protein species by the heat shock protein 70

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfolding in Enteric Neuron

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The molecular basis of this hypothesis centers on the structural and biochemical

Test: TREM2 enhances amyloid clearance

Score: 0.712 · unknown disease · 2026-04-17

## Mechanistic Overview Test: TREM2 enhances amyloid clearance starts from the claim that modulating not yet specified w

Test: TREM2 enhances amyloid clearance

Score: 0.705 · unknown disease · 2026-04-04

**Background and Rationale** Test: TREM2 enhances amyloid clearance is a mechanistic proposition centered on the idea t

Excess orexin-A worsens AD cognition through wake-driven amyloid production

Score: 0.686 · neurodegeneration · 2026-04-26

Chronic orexin-A elevation may aggravate AD by extending wakefulness, fragmenting circadian rhythms, and increasing acti

TREM2 Microglial Activation Rescues Amyloid Clearance in AD

Score: 0.680 · neurodegeneration · 2026-04-26

TREM2 agonistic antibodies restore microglial phagocytosis and plaque compaction in Alzheimer's disease, particularly fo

Test: TREM2 enhances amyloid clearance

Score: 0.655 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) represents a critical mi

Amyloid-beta induces secondary pericyte senescence after contractile and oxidati

Score: 0.640 · neurodegeneration · 2026-04-25

Soluble Aβ oligomers trigger endothelin-1 and ROS-dependent pericyte contractile stress, and repeated exposure converts

Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase

Score: 0.637 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase starts from the

Test: TREM2 enhances amyloid clearance

Score: 0.637 · unknown disease · 2026-04-17

**Molecular Mechanism and Rationale** TREM2 (Triggering Receptor Expressed on Myeloid cells 2) functions as a critical

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

Score: 0.630 · neurodegeneration · 2026-04-25

Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal